ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE

ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE was reported 1019 times

ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NASAL ASPIRATION 1 0.2500
1 MELATONIN DEFICIENCY 1 0.0714
2 COLPOCELE 1 0.0370
3 INTRANASAL PARAESTHESIA 1 0.0200
4 TISSUE DISCOLOURATION 1 0.0175
5 ELECTROCARDIOGRAM LOW VOLTAGE 1 0.0132
6 CHRONIC IDIOPATHIC PAIN SYNDROME 1 0.0125
7 TRANSIENT PSYCHOSIS 1 0.0122
8 PALATE INJURY 1 0.0120
9 MANDIBULAR MASS 1 0.0114
10 THYROID ATROPHY 1 0.0106
11 SWOLLEN TEAR DUCT 1 0.0094
12 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0088
13 VULVAR EROSION 1 0.0071
14 DRUG EFFECT DELAYED 20 0.0044
15 EUSTACHIAN TUBE DISORDER 1 0.0042
16 FOREIGN BODY IN THROAT 13 0.0041
17 CRIME 1 0.0038
18 LOWER RESPIRATORY TRACT INFLAMMATION 1 0.0037
19 GENITAL BLISTER 1 0.0036
20 OESOPHAGEAL FOOD IMPACTION 2 0.0036
21 VULVAL ULCERATION 1 0.0035
22 BLOOD IMMUNOGLOBULIN M INCREASED 2 0.0033
23 DRUG EFFECT DECREASED 161 0.0030
24 RENAL VEIN THROMBOSIS 2 0.0030
25 EPIDERMOLYSIS 1 0.0022
26 THERAPEUTIC PRODUCT INEFFECTIVE 8 0.0021
27 ANTIBIOTIC THERAPY 2 0.0020
28 RETROGRADE AMNESIA 1 0.0020
29 PRODUCT BLISTER PACKAGING ISSUE 2 0.0019
30 AUTOSCOPY 1 0.0019
31 PNEUMONIA INFLUENZAL 2 0.0017
32 RENAL TUBULAR INJURY 2 0.0016
33 PERIORAL DERMATITIS 1 0.0016
34 PARASOMNIA 1 0.0014
35 LIP EROSION 1 0.0014
36 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
37 MYCOPLASMA INFECTION 1 0.0013
38 HYPERVIGILANCE 1 0.0010
39 EXPIRED DRUG ADMINISTERED 5 0.0010
40 CLAUSTROPHOBIA 1 0.0009
41 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
42 PNEUMONIA STREPTOCOCCAL 1 0.0009
43 LIP ULCERATION 1 0.0009
44 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
45 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
46 PERIPHERAL ARTERY OCCLUSION 1 0.0007
47 NOROVIRUS INFECTION 1 0.0007
48 VASCULAR INJURY 1 0.0007
49 SOMNOLENCE 131 0.0006
50 ORAL MUCOSAL ERYTHEMA 1 0.0006
51 EYE ALLERGY 1 0.0006
52 BACTERIAL VAGINOSIS 1 0.0006
53 NASAL ULCER 1 0.0006
54 CHOKING 12 0.0006
55 BLOOD CALCIUM ABNORMAL 1 0.0006
56 SEIZURE LIKE PHENOMENA 1 0.0006
57 BODY TEMPERATURE ABNORMAL 1 0.0005
58 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
59 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
60 ATRIAL TACHYCARDIA 1 0.0005
61 RENAL NEOPLASM 1 0.0005
62 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
63 LIMB MASS 1 0.0005
64 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
65 OCULAR DISCOMFORT 5 0.0004
66 CYTOMEGALOVIRUS COLITIS 1 0.0004
67 SEASONAL ALLERGY 6 0.0004
68 URINARY HESITATION 1 0.0004
69 GASTROINTESTINAL OBSTRUCTION 1 0.0004
70 STARING 1 0.0004
71 LYMPHADENITIS 1 0.0004
72 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
73 INCREASED UPPER AIRWAY SECRETION 2 0.0004
74 RESPIRATORY TRACT CONGESTION 6 0.0004
75 RHINALGIA 1 0.0004
76 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
77 EOSINOPHILIC OESOPHAGITIS 1 0.0004
78 RESPIRATORY SYMPTOM 1 0.0004
79 PHARYNGEAL DISORDER 1 0.0003
80 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
81 BILIARY COLIC 1 0.0003
82 SINUS HEADACHE 2 0.0003
83 LOSS OF EMPLOYMENT 1 0.0003
84 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
85 SECRETION DISCHARGE 4 0.0003
86 PRODUCT USE COMPLAINT 5 0.0003
87 PRODUCT PACKAGING ISSUE 3 0.0003
88 BILE DUCT STONE 1 0.0003
89 ORTHOPNOEA 1 0.0003
90 STUPOR 1 0.0003
91 SKIN EROSION 1 0.0003
92 PLASMA CELL MYELOMA RECURRENT 1 0.0003
93 INJECTION SITE INFECTION 1 0.0003
94 INFUSION SITE HAEMORRHAGE 1 0.0003
95 PROSTATE CANCER METASTATIC 1 0.0003
96 REGURGITATION 1 0.0003
97 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
98 HYPOPNOEA 1 0.0003
99 EAR PRURITUS 1 0.0003
100 UNEVALUABLE EVENT 21 0.0003
101 BLOOD PHOSPHORUS DECREASED 1 0.0003
102 PARANASAL SINUS DISCOMFORT 1 0.0003
103 PARANASAL SINUS HYPERSECRETION 1 0.0003
104 THYROID MASS 1 0.0003
105 PROSTATOMEGALY 1 0.0003
106 SINUS DISORDER 5 0.0003
107 ENURESIS 1 0.0002
108 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
109 PERIPHERAL VENOUS DISEASE 1 0.0002
110 HYPERAESTHESIA 2 0.0002
111 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
112 EXPIRED PRODUCT ADMINISTERED 8 0.0002
113 UTERINE HAEMORRHAGE 1 0.0002
114 MUSCLE STRAIN 2 0.0002
115 OCULAR ICTERUS 1 0.0002
116 CHAPPED LIPS 1 0.0002
117 DYSPHEMIA 1 0.0002
118 GINGIVAL SWELLING 1 0.0002
119 WHEELCHAIR USER 1 0.0002
120 URINARY TRACT DISORDER 1 0.0002
121 URINE ABNORMALITY 1 0.0002
122 RHINORRHOEA 14 0.0002
123 DRUG ABUSE 18 0.0002
124 SKIN ABRASION 1 0.0002
125 APHAGIA 1 0.0002
126 INCORRECT DOSAGE ADMINISTERED 1 0.0002
127 HYPOAESTHESIA ORAL 3 0.0002
128 CORONARY ARTERIAL STENT INSERTION 1 0.0002
129 PATHOLOGICAL FRACTURE 1 0.0002
130 TOOTH ABSCESS 2 0.0002
131 WEIGHT FLUCTUATION 2 0.0002
132 SENSITIVITY TO WEATHER CHANGE 1 0.0002
133 PNEUMOTHORAX 3 0.0002
134 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
135 PRODUCT SIZE ISSUE 1 0.0002
136 SKIN LACERATION 2 0.0002
137 FAECALOMA 1 0.0002
138 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
139 THROAT IRRITATION 8 0.0002
140 PERIORBITAL SWELLING 1 0.0002
141 GRANULOCYTOPENIA 1 0.0002
142 HERPES VIRUS INFECTION 1 0.0002
143 MOUTH SWELLING 1 0.0002
144 HYPERVENTILATION 1 0.0002
145 ELECTROLYTE IMBALANCE 2 0.0002
146 PRODUCT LABEL CONFUSION 1 0.0002
147 SPINAL PAIN 2 0.0002
148 URINE ODOUR ABNORMAL 1 0.0002
149 THIRST 3 0.0002
150 CARDIAC PACEMAKER INSERTION 1 0.0002
151 ODYNOPHAGIA 1 0.0002
152 SYMPTOM RECURRENCE 1 0.0002
153 DRUG INEFFECTIVE 220 0.0002
154 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
155 INJECTION SITE VESICLES 1 0.0002
156 TENSION 1 0.0002
157 PRE-EXISTING CONDITION IMPROVED 1 0.0002
158 NASAL DRYNESS 1 0.0002
159 INFUSION SITE SWELLING 1 0.0002
160 PHOTOPSIA 1 0.0002
161 THERAPEUTIC RESPONSE CHANGED 1 0.0002
162 FEELING JITTERY 3 0.0002
163 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
164 CARDIAC FLUTTER 1 0.0002
165 POOR QUALITY DRUG ADMINISTERED 1 0.0002
166 WALKING AID USER 1 0.0002
167 POST-TRAUMATIC STRESS DISORDER 1 0.0001
168 SINUS CONGESTION 2 0.0001
169 EYE MOVEMENT DISORDER 1 0.0001
170 ECCHYMOSIS 1 0.0001
171 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
172 DROOLING 1 0.0001
173 APHONIA 2 0.0001
174 RIGHT VENTRICULAR FAILURE 1 0.0001
175 OXYGEN SATURATION DECREASED 8 0.0001
176 HALLUCINATION, VISUAL 3 0.0001
177 PAPULE 1 0.0001
178 OROPHARYNGEAL PAIN 13 0.0001
179 PARAESTHESIA ORAL 2 0.0001
180 ORAL DISORDER 1 0.0001
181 HYPOPHOSPHATAEMIA 1 0.0001
182 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
183 CEREBRAL DISORDER 1 0.0001
184 BLOOD PRESSURE INCREASED 20 0.0001
185 FOOD ALLERGY 1 0.0001
186 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
187 PELVIC FRACTURE 1 0.0001
188 GASTROINTESTINAL INFLAMMATION 1 0.0001
189 NASAL DISCOMFORT 1 0.0001
190 ULCER 2 0.0001
191 BLOOD DISORDER 1 0.0001
192 FRUSTRATION TOLERANCE DECREASED 1 0.0001
193 DECUBITUS ULCER 1 0.0001
194 POLYURIA 1 0.0001
195 ABNORMAL FAECES 1 0.0001
196 BRONCHITIS 9 0.0001
197 URINARY RETENTION 4 0.0001
198 NASOPHARYNGITIS 22 0.0001
199 SENSATION OF FOREIGN BODY 1 0.0001
200 INFUSION SITE ERYTHEMA 1 0.0001
201 CARDIAC OPERATION 1 0.0001
202 BLOOD MAGNESIUM DECREASED 1 0.0001
203 PSYCHOLOGICAL TRAUMA 1 0.0001
204 CARDIAC MURMUR 1 0.0001
205 RESPIRATORY TRACT INFECTION 3 0.0001
206 LOCAL SWELLING 2 0.0001
207 GROIN PAIN 1 0.0001
208 TUMOUR LYSIS SYNDROME 1 0.0001
209 RESPIRATORY RATE INCREASED 1 0.0001
210 FACIAL PAIN 1 0.0001
211 GASTROINTESTINAL INFECTION 1 0.0001
212 THROAT TIGHTNESS 3 0.0001
213 TOOTHACHE 2 0.0001
214 LIMB INJURY 3 0.0001
215 LIP DRY 1 0.0001
216 END STAGE RENAL DISEASE 2 0.0001
217 INTENTIONAL OVERDOSE 7 0.0001
218 PRODUCT DISTRIBUTION ISSUE 1 0.0001
219 SINUSITIS 11 0.0001
220 ERYTHEMA MULTIFORME 1 0.0001
221 MIDDLE INSOMNIA 2 0.0001
222 LACERATION 1 0.0001
223 SQUAMOUS CELL CARCINOMA 1 0.0001
224 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
225 BLOOD PRESSURE DECREASED 7 0.0001
226 EYE INFLAMMATION 1 0.0001
227 DIZZINESS POSTURAL 1 0.0001
228 AUTOIMMUNE DISORDER 1 0.0001
229 PHARYNGEAL SWELLING 1 0.0001
230 COELIAC DISEASE 1 0.0001
231 LIGAMENT SPRAIN 1 0.0001
232 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
233 PRODUCT PHYSICAL ISSUE 2 0.0001
234 THERAPEUTIC RESPONSE DECREASED 6 0.0001
235 VAGINAL DISCHARGE 1 0.0001
236 DRY MOUTH 8 0.0001
237 DRY THROAT 1 0.0001
238 DRUG LEVEL DECREASED 1 0.0001
239 MOTOR DYSFUNCTION 1 0.0001
240 EUPHORIC MOOD 1 0.0001
241 VENTRICULAR EXTRASYSTOLES 1 0.0001
242 COUGH 27 0.0001
243 EYE DISCHARGE 1 0.0001
244 INCONTINENCE 1 0.0001
245 POOR QUALITY SLEEP 2 0.0001
246 SKIN CANCER 2 0.0001
247 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
248 WOUND INFECTION 1 0.0001
249 ASPIRATION 1 0.0001
250 EYE DISORDER 3 0.0001
251 GASTROINTESTINAL PAIN 1 0.0001
252 INFLUENZA 10 0.0001
253 SNEEZING 2 0.0001
254 CHROMATURIA 2 0.0001
255 EYE INFECTION 1 0.0001
256 HEART RATE IRREGULAR 2 0.0001
257 FEELING ABNORMAL 21 0.0001
258 MICTURITION URGENCY 1 0.0001
259 GASTRIC HAEMORRHAGE 1 0.0001
260 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
261 HEART RATE DECREASED 3 0.0001
262 PALPITATIONS 10 0.0001
263 COVID-19 PNEUMONIA 1 0.0001
264 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
265 MUSCLE RIGIDITY 1 0.0001
266 LOCALISED INFECTION 2 0.0001
267 DRUG EFFECT INCOMPLETE 3 0.0001
268 BURSITIS 1 0.0001
269 SCHIZOPHRENIA 1 0.0001
270 FIBROMYALGIA 2 0.0001
271 TENDON RUPTURE 1 0.0001
272 CYST 1 0.0001
273 EPISTAXIS 6 0.0001
274 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
275 MYDRIASIS 1 0.0001
276 INFUSION SITE PAIN 1 0.0001
277 ANAPHYLACTIC SHOCK 2 0.0001
278 NODULE 1 0.0001
279 NERVOUSNESS 4 0.0001
280 IMMUNE SYSTEM DISORDER 1 0.0001
281 TOOTH INFECTION 1 0.0001
282 SARS-COV-2 TEST POSITIVE 1 0.0001
283 ADVERSE REACTION 1 0.0001
284 EAR INFECTION 2 0.0001
285 EYE HAEMORRHAGE 1 0.0001
286 MALIGNANT MELANOMA 1 0.0001
287 QUALITY OF LIFE DECREASED 1 0.0001
288 ABNORMAL DREAMS 2 0.0001
289 ORAL DISCOMFORT 1 0.0001
290 HUNGER 1 0.0001
291 NECK PAIN 4 0.0001
292 BLOOD TEST ABNORMAL 1 0.0001
293 DIZZINESS 35 0.0001
294 PARALYSIS 1 0.0001
295 ANGINA PECTORIS 2 0.0001
296 HYPERSOMNIA 2 0.0001
297 HYPOACUSIS 3 0.0001
298 FLUID OVERLOAD 1 0.0001
299 APATHY 1 0.0001
300 INTENTIONAL PRODUCT MISUSE 6 0.0001
301 DYSSTASIA 2 0.0001
302 DYSPHONIA 4 0.0001
303 NASAL CONGESTION 4 0.0001
304 ILLNESS 7 0.0001
305 CARDIOMYOPATHY 1 0.0001
306 RESPIRATORY DISORDER 2 0.0001
307 HOT FLUSH 5 0.0001
308 HIP ARTHROPLASTY 1 0.0001
309 SKIN DISCOLOURATION 3 0.0001
310 HYPOKALAEMIA 3 0.0001
311 MUSCULOSKELETAL CHEST PAIN 1 0.0001
312 BASAL CELL CARCINOMA 1 0.0001
313 HEAD INJURY 2 0.0001
314 DISEASE RECURRENCE 3 0.0001
315 PRODUCTIVE COUGH 3 0.0001
316 ABSCESS 1 0.0001
317 LOSS OF CONSCIOUSNESS 8 0.0001
318 SENSORY DISTURBANCE 1 0.0001
319 SWELLING FACE 4 0.0001
320 CHOLELITHIASIS 2 0.0001
321 METASTASES TO BONE 1 0.0001
322 IMPAIRED HEALING 2 0.0001
323 MULTIPLE FRACTURES 1 0.0001
324 HEART RATE INCREASED 6 0.0001
325 PHOTOSENSITIVITY REACTION 1 0.0001
326 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
327 FACE OEDEMA 1 0.0001
328 HEADACHE 37 0.0001
329 PRODUCT USE ISSUE 11 0.0001
330 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
331 COLD SWEAT 1 0.0001
332 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
333 DRUG ERUPTION 1 0.0001
334 DECREASED APPETITE 13 0.0001
335 DISTURBANCE IN ATTENTION 3 0.0001
336 ACCIDENTAL OVERDOSE 2 0.0001
337 BLOOD GLUCOSE ABNORMAL 1 0.0001
338 CONJUNCTIVITIS 1 0.0001
339 HYPERSENSITIVITY 10 0.0001
340 DYSGEUSIA 4 0.0001
341 AGRANULOCYTOSIS 1 0.0001
342 EYE SWELLING 2 0.0001
343 BACTERIAL INFECTION 1 0.0001
344 DYSARTHRIA 2 0.0001
345 DYSPNOEA 30 0.0001
346 FOOT FRACTURE 1 0.0001
347 CHRONIC KIDNEY DISEASE 4 0.0001
348 DEHYDRATION 7 0.0001
349 SLEEP APNOEA SYNDROME 1 0.0001
350 PULMONARY FIBROSIS 1 0.0001
351 ACUTE RESPIRATORY FAILURE 1 0.0001
352 PRESCRIBED OVERDOSE 1 0.0001
353 EAR PAIN 1 0.0001
354 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
355 ORAL HERPES 1 0.0001
356 SURGERY 3 0.0001
357 KIDNEY INFECTION 1 0.0001
358 ARTHRITIS 4 0.0001
359 BLOOD PRESSURE ABNORMAL 1 0.0001
360 PRESCRIBED UNDERDOSE 1 0.0001
361 SPINAL FRACTURE 1 0.0000
362 PRODUCT ADMINISTRATION ERROR 1 0.0000
363 TASTE DISORDER 1 0.0000
364 BODY TEMPERATURE INCREASED 1 0.0000
365 CHEST DISCOMFORT 5 0.0000
366 INSOMNIA 13 0.0000
367 FATIGUE 38 0.0000
368 RIB FRACTURE 1 0.0000
369 PULMONARY HYPERTENSION 1 0.0000
370 EATING DISORDER 1 0.0000
371 RETCHING 1 0.0000
372 PRURITUS GENERALISED 1 0.0000
373 FAECES DISCOLOURED 1 0.0000
374 AMNESIA 3 0.0000
375 OFF LABEL USE 40 0.0000
376 COVID-19 8 0.0000
377 GLOSSODYNIA 1 0.0000
378 ORAL PAIN 1 0.0000
379 RASH PAPULAR 1 0.0000
380 THERAPY NON-RESPONDER 2 0.0000
381 ABDOMINAL PAIN UPPER 9 0.0000
382 RENAL DISORDER 2 0.0000
383 BURNING SENSATION 3 0.0000
384 CHILLS 5 0.0000
385 SLEEP DISORDER 3 0.0000
386 OCULAR HYPERAEMIA 2 0.0000
387 RASH ERYTHEMATOUS 2 0.0000
388 ABDOMINAL DISCOMFORT 7 0.0000
389 BLOOD PRESSURE FLUCTUATION 1 0.0000
390 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
391 MENTAL IMPAIRMENT 1 0.0000
392 PRESYNCOPE 1 0.0000
393 LIVER INJURY 1 0.0000
394 AGEUSIA 1 0.0000
395 CELLULITIS 2 0.0000
396 PRODUCT COMPLAINT 1 0.0000
397 ERYTHEMA 8 0.0000
398 DIARRHOEA 25 0.0000
399 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
400 JOINT STIFFNESS 1 0.0000
401 DRY SKIN 5 0.0000
402 PRODUCT DOSE OMISSION ISSUE 11 0.0000
403 PNEUMONITIS 1 0.0000
404 DEPENDENCE 2 0.0000
405 PRURITUS 14 0.0000
406 HAEMATOCHEZIA 2 0.0000
407 MENTAL STATUS CHANGES 1 0.0000
408 MEDICATION ERROR 2 0.0000
409 FEELING COLD 1 0.0000
410 WEIGHT DECREASED 10 0.0000
411 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
412 FLATULENCE 2 0.0000
413 HERPES ZOSTER 2 0.0000
414 BALANCE DISORDER 3 0.0000
415 SEIZURE 4 0.0000
416 LIVER FUNCTION TEST ABNORMAL 1 0.0000
417 NEEDLE ISSUE 1 0.0000
418 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
419 ACUTE MYOCARDIAL INFARCTION 1 0.0000
420 CATARACT 2 0.0000
421 IRRITABILITY 2 0.0000
422 LACRIMATION INCREASED 1 0.0000
423 HYPERTENSION 7 0.0000
424 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
425 CONDITION AGGRAVATED 10 0.0000
426 PLEURAL EFFUSION 2 0.0000
427 VERTIGO 2 0.0000
428 INJECTION SITE RASH 1 0.0000
429 DRUG ADMINISTRATION ERROR 1 0.0000
430 PERIPHERAL SWELLING 5 0.0000
431 OVERDOSE 7 0.0000
432 CONSTIPATION 7 0.0000
433 SWOLLEN TONGUE 1 0.0000
434 DRUG-INDUCED LIVER INJURY 1 0.0000
435 DYSPHAGIA 3 0.0000
436 CYSTITIS 1 0.0000
437 METABOLIC ACIDOSIS 1 0.0000
438 HIP FRACTURE 1 0.0000
439 HYPERHIDROSIS 4 0.0000
440 ATRIAL FIBRILLATION 3 0.0000
441 DYSPEPSIA 3 0.0000
442 BACK PAIN 7 0.0000
443 LIP SWELLING 1 0.0000
444 FUNGAL INFECTION 1 0.0000
445 SKIN DISORDER 1 0.0000
446 ANGER 1 0.0000
447 FLUSHING 3 0.0000
448 HEPATIC ENZYME INCREASED 2 0.0000
449 URINARY TRACT INFECTION 5 0.0000
450 GASTRIC DISORDER 1 0.0000
451 DELIRIUM 1 0.0000
452 NEOPLASM PROGRESSION 1 0.0000
453 ABDOMINAL DISTENSION 3 0.0000
454 HYPOXIA 1 0.0000
455 LYMPHADENOPATHY 1 0.0000
456 THERAPY INTERRUPTED 2 0.0000
457 SKIN BURNING SENSATION 2 0.0000
458 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
459 PNEUMONIA 9 0.0000
460 RASH 12 0.0000
461 CRYING 1 0.0000
462 PANIC ATTACK 1 0.0000
463 UNDERDOSE 2 0.0000
464 MALAISE 12 0.0000
465 MUSCLE SPASMS 5 0.0000
466 AGITATION 2 0.0000
467 DYSURIA 1 0.0000
468 CHEST PAIN 5 0.0000
469 HALLUCINATION 2 0.0000
470 BLOOD GLUCOSE INCREASED 5 0.0000
471 COLITIS 1 0.0000
472 HOSPITALISATION 4 0.0000
473 PLASMA CELL MYELOMA 1 0.0000
474 PARAESTHESIA 4 0.0000
475 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
476 NAUSEA 20 0.0000
477 HYPOTENSION 5 0.0000
478 DRUG DEPENDENCE 4 0.0000
479 THROMBOSIS 2 0.0000
480 JOINT SWELLING 3 0.0000
481 EXTRA DOSE ADMINISTERED 1 0.0000
482 OSTEOPOROSIS 1 0.0000
483 TREMOR 4 0.0000
484 FALL 8 0.0000
485 POLLAKIURIA 1 0.0000
486 ASTHENIA 9 0.0000
487 ROAD TRAFFIC ACCIDENT 1 0.0000
488 URTICARIA 4 0.0000
489 RENAL IMPAIRMENT 2 0.0000
490 SKIN EXFOLIATION 2 0.0000
491 MYALGIA 4 0.0000
492 RECTAL HAEMORRHAGE 1 0.0000
493 MENTAL DISORDER 1 0.0000
494 WEIGHT INCREASED 5 0.0000
495 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
496 INCORRECT DOSE ADMINISTERED 5 0.0000
497 MEMORY IMPAIRMENT 3 0.0000
498 NEPHROLITHIASIS 1 0.0000
499 TINNITUS 1 0.0000
500 ADVERSE EVENT 2 0.0000
501 COGNITIVE DISORDER 1 0.0000
502 CARDIAC DISORDER 2 0.0000
503 SWELLING 2 0.0000
504 ARRHYTHMIA 1 0.0000
505 COMA 1 0.0000
506 RENAL CANCER 1 0.0000
507 MIGRAINE 2 0.0000
508 GAIT DISTURBANCE 4 0.0000
509 BLOOD GLUCOSE DECREASED 1 0.0000
510 INFECTION 3 0.0000
511 HYPOGLYCAEMIA 1 0.0000
512 LUNG DISORDER 1 0.0000
513 PAIN IN EXTREMITY 6 0.0000
514 PYREXIA 7 0.0000
515 HYPOAESTHESIA 3 0.0000
516 DRY EYE 1 0.0000
517 AGGRESSION 1 0.0000
518 VOMITING 9 0.0000
519 DEPRESSED MOOD 1 0.0000
520 BRADYCARDIA 1 0.0000
521 PLATELET COUNT DECREASED 2 0.0000
522 RASH PRURITIC 1 0.0000
523 PAIN 11 0.0000
524 EYE PAIN 1 0.0000
525 CEREBROVASCULAR ACCIDENT 3 0.0000
526 ASTHMA 2 0.0000
527 MUSCULAR WEAKNESS 2 0.0000
528 CONVULSION 1 0.0000
529 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
530 OEDEMA PERIPHERAL 2 0.0000
531 FEELING HOT 1 0.0000
532 EXPOSURE DURING PREGNANCY 1 0.0000
533 DEEP VEIN THROMBOSIS 1 0.0000
534 ALOPECIA 3 0.0000
535 RENAL FAILURE 2 0.0000
536 INJECTION SITE PRURITUS 1 0.0000
537 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
538 PRODUCT QUALITY ISSUE 2 0.0000
539 VISION BLURRED 2 0.0000
540 DEVICE MALFUNCTION 1 0.0000
541 INJURY 1 0.0000
542 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
543 ANXIETY 4 0.0000
544 ACNE 1 0.0000
545 DIABETES MELLITUS 1 0.0000
546 ACUTE KIDNEY INJURY 2 0.0000
547 DRUG INTERACTION 2 0.0000
548 CARDIAC FAILURE 1 0.0000
549 PROSTATE CANCER 1 0.0000
550 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
551 CONFUSIONAL STATE 2 0.0000
552 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
553 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
554 GASTROINTESTINAL DISORDER 1 0.0000
555 DEVICE ISSUE 1 0.0000
556 ADVERSE DRUG REACTION 1 0.0000
557 SUICIDAL IDEATION 1 0.0000
558 NEUROPATHY PERIPHERAL 1 0.0000
559 ANAEMIA 2 0.0000
560 CONTUSION 1 0.0000
561 SYNCOPE 1 0.0000
562 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
563 HAEMOGLOBIN DECREASED 1 0.0000
564 ARTHRALGIA 4 0.0000
565 HAEMORRHAGE 1 0.0000
566 DEATH 8 0.0000
567 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
568 ABDOMINAL PAIN 2 0.0000
569 DISEASE PROGRESSION 1 0.0000
570 EMOTIONAL DISTRESS 1 0.0000
571 VISUAL IMPAIRMENT 1 0.0000
572 INJECTION SITE ERYTHEMA 1 0.0000
573 TOXICITY TO VARIOUS AGENTS 1 0.0000
574 NO ADVERSE EVENT 1 0.0000
575 DEPRESSION 1 0.0000
576 INJECTION SITE PAIN 1 0.0000